Panntherapi PharmaRevolutionizing treatment for patients suffering from Neurological Diseases
An innovative pharmaceutical company
Panntherapi is a clinical stage biotech company dedicated to the development of innovative drugs, aiming for better efficacy and tolerance than current ones for the treatment of brain and nervous diseases.
INNOVATIONHigher efficacy, better safety
New Specific Target
Panntherapi innovates by selectively targeting the activated pannexin 1 channel, involved in the root cause of the diseases
1st in class Derisked Clinical Asset
A safe compound addressing an orphan epileptic syndrome mostly paediatric with a high medical need
New Chemical Entities
New scaffold with a high therapeutic potential in neurological and psychiatric disorders
Our Expertise
Panntherapi develops a Fisrt in Class derisked candidate, which can rapidly reach the market for paediatric epileptic patients with a high medical need and new chemical entities designed to address other neurological and psychiatric conditions.
There are no incurable diseases.
Only the lack of will.
Avicenna
980-1037
980-1037
© 2025 Panntherapi. All rights reserved